Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.

UCB

Status and phase: Completed; Phase 4

Conditions: Epilepsy, Partial

Treatments: Drug: levetiracetam

Study type: Interventional

Funder types: Industry

Identifiers

NCT00245713

N01085

Details and patient eligibility

About

Effect of adjunctive levetiracetam on polysomnography in adults with partial-onset epilepsy receiving a classical antiepileptic drug

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects must have partial onset epilepsy and have been taking carbamazepine or phenytoin at a stable dose for a period of 4 weeks prior to the selection visit
• Subjects must have controlled partial onset seizures which can potentially benefit from adjunctive treatment

Exclusion criteria

• Subjects dosing with LEV two weeks prior to the selection visit
• Subjects using more than one AED
• Subjects with specific and non-specific sleep disorders